Other OTC - Delayed Quote USD

Curaleaf Holdings, Inc. (CURLF)

4.9790 +0.0290 (+0.59%)
As of 3:01 PM EDT. Market Open.
Loading Chart for CURLF
DELL
  • Previous Close 4.9500
  • Open 4.9600
  • Bid --
  • Ask --
  • Day's Range 4.9000 - 5.0500
  • 52 Week Range 2.2800 - 5.9100
  • Volume 235,009
  • Avg. Volume 908,938
  • Market Cap (intraday) 3.655B
  • Beta (5Y Monthly) 1.60
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3200
  • Earnings Date May 9, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.49

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.

www.curaleaf.com

5,650

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CURLF

Performance Overview: CURLF

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CURLF
22.64%
S&P/TSX Composite index
4.31%

1-Year Return

CURLF
114.61%
S&P/TSX Composite index
5.65%

3-Year Return

CURLF
62.18%
S&P/TSX Composite index
14.45%

5-Year Return

CURLF
53.73%
S&P/TSX Composite index
31.15%

Compare To: CURLF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CURLF

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    3.62B

  • Enterprise Value

    4.42B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.66

  • Price/Book (mrq)

    3.47

  • Enterprise Value/Revenue

    3.28

  • Enterprise Value/EBITDA

    23.49

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -20.88%

  • Return on Assets (ttm)

    0.82%

  • Return on Equity (ttm)

    -18.58%

  • Revenue (ttm)

    1.35B

  • Net Income Avi to Common (ttm)

    -229.82M

  • Diluted EPS (ttm)

    -0.3200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    91.82M

  • Total Debt/Equity (mrq)

    93.76%

  • Levered Free Cash Flow (ttm)

    296.6M

Research Analysis: CURLF

Analyst Price Targets

3.50 Low
5.49 Average
4.9790 Current
7.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: CURLF

Research Reports: CURLF

  • Analyst Report: Curaleaf Holdings, Inc.

    Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.

    Rating
    Price Target
     
  • Analyst Report: Curaleaf Holdings, Inc.

    Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.

    Rating
    Price Target
     
  • Analyst Report: Curaleaf Holdings, Inc.

    Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.

    Rating
    Price Target
     
  • Analyst Report: Curaleaf Holdings, Inc.

    Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.

    Rating
    Price Target
     

People Also Watch